Glyn Stacey has a background in microbiology and cancer research and has worked on the development of cell substrates for manufacture of biological medicines for over fifteen years. He is currently at the National Institute for Biological Standards and Control which is a part of the Medicines and Healthcare Products Regulatory Agency. He is Head of Division of Cell Biology and Imaging and Director for the UK Stem Cell Bank (UKSCB). The UKSCB has been a licensed clinical tissue bank since 2004. The work of his group covers safety and quality issues in cell therapy, cells used for manufacturing purposes, development of novel cell-based assays and the development of reference materials for tissue typing and diagnosis of genetic disorders. This work includes the need for scale up of preservation techniques and long term storage of DNA and cell lines of various types including human stem cell lines and cells used in bioassays and vaccine production.
Glyn has served on numerous steering groups for organisations promoting and funding regenerative medicine. He has also chaired the UK National Clinical hESC Forum and the scientific advisory board for a Public Private Partnership not-for-profit company called Stem Cells for Safer Medicine. His academic roles include member of faculty for postgraduate courses in regenerative medicine at Kings College London and University College London, and he is a visiting Professor at the University of Bedfordshire in the UK.